Athena Heart [310] -

: Conduct regular ECGs to monitor for potential proarrhythmic effects or excessive QT prolongation.

Patients with paroxysmal or persistent AF or AFL who are in sinus rhythm or who will be cardioverted. ATHENA HEART [310]

: Dronedarone significantly reduced the primary composite endpoint of first cardiovascular hospitalization or death by 24% compared to a placebo. : Conduct regular ECGs to monitor for potential